NPPA Caps Cancer Drug Margins Affecting Max Healthcare, Apollo, Sun Pharma
The NPPA has capped trade margins at 30% on 137 anti-cancer drugs, effective November 9, 2026. This move aims to reduce maximum retail prices by up to 70%, impacting companies like Max Healthcare, Apollo Hospitals, Sun Pharma, and Dr Reddy’s.
Read